Physician profile
Jon Sherman
NPI 1366443053
$11,478.11
in general payments reported to CMS, 2019-2025
42 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $1,307 · 2021: $1,803 · 2022: $2,915 · 2023: $980 · 2024: $1,616 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,003 · Travel and Lodging: $172 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,002.59 |
| Travel and Lodging | $171.95 |
| Education | $159.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,740.25 | 2019-2025 | |
| Boston Scientific Corporation | $968.45 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Ams 700, Watchman Access System |
| Janssen Pharmaceuticals, INC | $922.79 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.42 | 2019-2025 | Jardiance |
| Amgen INC. | $884.04 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $573.88 | 2019-2025 | Xience Skypoint, Aveir, Pressurewire |
| Medtronic, INC. | $554.70 | 2021-2025 | Synchromedii, Linq II, Micra |
| Astrazeneca Pharmaceuticals Lp | $551.65 | 2019-2025 | Brilinta, Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $439.60 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $397.59 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $295.50 | 2022-2025 | Amvuttra, Onpattro |
| Medtronic Vascular, INC. | $291.82 | 2019-2020 | |
| Edwards Lifesciences Corporation | $290.62 | 2022 | |
| Impulse Dynamics (USA) INC. | $265.43 | 2025 | Optimizer |
| Pfizer INC. | $263.72 | 2019-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.